Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
Identifieur interne : 002797 ( PubMed/Curation ); précédent : 002796; suivant : 002798Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
Auteurs : Yan Zhi [États-Unis] ; Gary P. Kobinger ; Heather Jordan ; Katie Suchma ; Susan R. Weiss ; Hao Shen ; Gregory Schumer ; Guangping Gao ; Julie L. Boyer ; Ronald G. Crystal ; James M. WilsonSource :
- Virology [ 0042-6822 ] ; 2005.
Descripteurs français
- KwdFr :
- Adénovirus humains (génétique), Adénovirus humains (immunologie), Adénovirus humains (métabolisme), Animaux, Antigène d'histocompatibilité H2-D, Antigènes H-2 (métabolisme), Cartographie épitopique, Cellules Vero, Codon, Données de séquences moléculaires, Déterminants antigéniques des lymphocytes T (immunologie), Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (génétique), Glycoprotéines membranaires (immunologie), Humains, Immunisation, Lignée cellulaire, Lymphocytes T CD8+ (immunologie), Peptides (), Peptides (immunologie), Protéines de l'enveloppe virale (génétique), Protéines de l'enveloppe virale (immunologie), Souris, Souris de lignée BALB C, Souris de lignée C57BL, Syndrome respiratoire aigu sévère (), Séquence d'acides aminés, Vaccins antiviraux (administration et posologie), Vaccins antiviraux (immunologie), Vecteurs génétiques (administration et posologie), Vecteurs génétiques (immunologie), Virus du SRAS (immunologie).
- MESH :
- administration et posologie : Vaccins antiviraux, Vecteurs génétiques.
- génétique : Adénovirus humains, Glycoprotéines membranaires, Protéines de l'enveloppe virale.
- immunologie : Adénovirus humains, Déterminants antigéniques des lymphocytes T, Glycoprotéines membranaires, Lymphocytes T CD8+, Peptides, Protéines de l'enveloppe virale, Vaccins antiviraux, Vecteurs génétiques, Virus du SRAS.
- métabolisme : Adénovirus humains, Antigènes H-2.
- Animaux, Antigène d'histocompatibilité H2-D, Cartographie épitopique, Cellules Vero, Codon, Données de séquences moléculaires, Glycoprotéine de spicule des coronavirus, Humains, Immunisation, Lignée cellulaire, Peptides, Souris, Souris de lignée BALB C, Souris de lignée C57BL, Syndrome respiratoire aigu sévère, Séquence d'acides aminés.
English descriptors
- KwdEn :
- Adenoviruses, Human (genetics), Adenoviruses, Human (immunology), Adenoviruses, Human (metabolism), Amino Acid Sequence, Animals, CD8-Positive T-Lymphocytes (immunology), Cell Line, Chlorocebus aethiops, Codon, Epitope Mapping, Epitopes, T-Lymphocyte (immunology), Genetic Vectors (administration & dosage), Genetic Vectors (immunology), H-2 Antigens (metabolism), Histocompatibility Antigen H-2D, Humans, Immunization, Membrane Glycoproteins (genetics), Membrane Glycoproteins (immunology), Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Molecular Sequence Data, Peptides (chemistry), Peptides (immunology), SARS Virus (immunology), Severe Acute Respiratory Syndrome (prevention & control), Spike Glycoprotein, Coronavirus, Vero Cells, Viral Envelope Proteins (genetics), Viral Envelope Proteins (immunology), Viral Vaccines (administration & dosage), Viral Vaccines (immunology).
- MESH :
- chemical , administration & dosage : Viral Vaccines.
- chemical , chemistry : Peptides.
- chemical , genetics : Membrane Glycoproteins, Viral Envelope Proteins.
- chemical , immunology : Epitopes, T-Lymphocyte, Membrane Glycoproteins, Peptides, Viral Envelope Proteins, Viral Vaccines.
- chemical , metabolism : H-2 Antigens.
- chemical : Codon, Histocompatibility Antigen H-2D, Spike Glycoprotein, Coronavirus.
- administration & dosage : Genetic Vectors.
- genetics : Adenoviruses, Human.
- immunology : Adenoviruses, Human, CD8-Positive T-Lymphocytes, Genetic Vectors, SARS Virus.
- metabolism : Adenoviruses, Human.
- prevention & control : Severe Acute Respiratory Syndrome.
- Amino Acid Sequence, Animals, Cell Line, Chlorocebus aethiops, Epitope Mapping, Humans, Immunization, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Molecular Sequence Data, Vero Cells.
Abstract
The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding codon-optimized SARS-CoV spike protein. CD8 T-cell responses were mapped to two H-2(b)-restricted epitopes (S436-443 and S525-532) and one H-2(d)-restricted epitope (S366-374). The identification of these epitopes will facilitate the evaluation of vaccine strategies in murine models of SARS-CoV infection. Furthermore, codon and promoter optimizations can greatly enhance the overall immunogenicity of spike protein in the context of replication-defective human and simian adenoviral vaccine carriers. The optimized recombinant adenoviral vaccine vectors encoding spike can generate robust antigen-specific cellular immunity in mice and may potentially be useful for control of SARS-CoV infection.
DOI: 10.1016/j.virol.2005.01.050
PubMed: 15823604
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002797
Links to Exploration step
pubmed:15823604Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.</title><author><name sortKey="Zhi, Yan" sort="Zhi, Yan" uniqKey="Zhi Y" first="Yan" last="Zhi">Yan Zhi</name><affiliation wicri:level="1"><nlm:affiliation>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, and The Wistar Institute, Philadelphia, PA 19104, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, and The Wistar Institute, Philadelphia, PA 19104</wicri:regionArea></affiliation></author><author><name sortKey="Kobinger, Gary P" sort="Kobinger, Gary P" uniqKey="Kobinger G" first="Gary P" last="Kobinger">Gary P. Kobinger</name></author><author><name sortKey="Jordan, Heather" sort="Jordan, Heather" uniqKey="Jordan H" first="Heather" last="Jordan">Heather Jordan</name></author><author><name sortKey="Suchma, Katie" sort="Suchma, Katie" uniqKey="Suchma K" first="Katie" last="Suchma">Katie Suchma</name></author><author><name sortKey="Weiss, Susan R" sort="Weiss, Susan R" uniqKey="Weiss S" first="Susan R" last="Weiss">Susan R. Weiss</name></author><author><name sortKey="Shen, Hao" sort="Shen, Hao" uniqKey="Shen H" first="Hao" last="Shen">Hao Shen</name></author><author><name sortKey="Schumer, Gregory" sort="Schumer, Gregory" uniqKey="Schumer G" first="Gregory" last="Schumer">Gregory Schumer</name></author><author><name sortKey="Gao, Guangping" sort="Gao, Guangping" uniqKey="Gao G" first="Guangping" last="Gao">Guangping Gao</name></author><author><name sortKey="Boyer, Julie L" sort="Boyer, Julie L" uniqKey="Boyer J" first="Julie L" last="Boyer">Julie L. Boyer</name></author><author><name sortKey="Crystal, Ronald G" sort="Crystal, Ronald G" uniqKey="Crystal R" first="Ronald G" last="Crystal">Ronald G. Crystal</name></author><author><name sortKey="Wilson, James M" sort="Wilson, James M" uniqKey="Wilson J" first="James M" last="Wilson">James M. Wilson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15823604</idno><idno type="pmid">15823604</idno><idno type="doi">10.1016/j.virol.2005.01.050</idno><idno type="wicri:Area/PubMed/Corpus">002797</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002797</idno><idno type="wicri:Area/PubMed/Curation">002797</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002797</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.</title><author><name sortKey="Zhi, Yan" sort="Zhi, Yan" uniqKey="Zhi Y" first="Yan" last="Zhi">Yan Zhi</name><affiliation wicri:level="1"><nlm:affiliation>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, and The Wistar Institute, Philadelphia, PA 19104, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, and The Wistar Institute, Philadelphia, PA 19104</wicri:regionArea></affiliation></author><author><name sortKey="Kobinger, Gary P" sort="Kobinger, Gary P" uniqKey="Kobinger G" first="Gary P" last="Kobinger">Gary P. Kobinger</name></author><author><name sortKey="Jordan, Heather" sort="Jordan, Heather" uniqKey="Jordan H" first="Heather" last="Jordan">Heather Jordan</name></author><author><name sortKey="Suchma, Katie" sort="Suchma, Katie" uniqKey="Suchma K" first="Katie" last="Suchma">Katie Suchma</name></author><author><name sortKey="Weiss, Susan R" sort="Weiss, Susan R" uniqKey="Weiss S" first="Susan R" last="Weiss">Susan R. Weiss</name></author><author><name sortKey="Shen, Hao" sort="Shen, Hao" uniqKey="Shen H" first="Hao" last="Shen">Hao Shen</name></author><author><name sortKey="Schumer, Gregory" sort="Schumer, Gregory" uniqKey="Schumer G" first="Gregory" last="Schumer">Gregory Schumer</name></author><author><name sortKey="Gao, Guangping" sort="Gao, Guangping" uniqKey="Gao G" first="Guangping" last="Gao">Guangping Gao</name></author><author><name sortKey="Boyer, Julie L" sort="Boyer, Julie L" uniqKey="Boyer J" first="Julie L" last="Boyer">Julie L. Boyer</name></author><author><name sortKey="Crystal, Ronald G" sort="Crystal, Ronald G" uniqKey="Crystal R" first="Ronald G" last="Crystal">Ronald G. Crystal</name></author><author><name sortKey="Wilson, James M" sort="Wilson, James M" uniqKey="Wilson J" first="James M" last="Wilson">James M. Wilson</name></author></analytic><series><title level="j">Virology</title><idno type="ISSN">0042-6822</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenoviruses, Human (genetics)</term><term>Adenoviruses, Human (immunology)</term><term>Adenoviruses, Human (metabolism)</term><term>Amino Acid Sequence</term><term>Animals</term><term>CD8-Positive T-Lymphocytes (immunology)</term><term>Cell Line</term><term>Chlorocebus aethiops</term><term>Codon</term><term>Epitope Mapping</term><term>Epitopes, T-Lymphocyte (immunology)</term><term>Genetic Vectors (administration & dosage)</term><term>Genetic Vectors (immunology)</term><term>H-2 Antigens (metabolism)</term><term>Histocompatibility Antigen H-2D</term><term>Humans</term><term>Immunization</term><term>Membrane Glycoproteins (genetics)</term><term>Membrane Glycoproteins (immunology)</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Mice, Inbred C57BL</term><term>Molecular Sequence Data</term><term>Peptides (chemistry)</term><term>Peptides (immunology)</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Spike Glycoprotein, Coronavirus</term><term>Vero Cells</term><term>Viral Envelope Proteins (genetics)</term><term>Viral Envelope Proteins (immunology)</term><term>Viral Vaccines (administration & dosage)</term><term>Viral Vaccines (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adénovirus humains (génétique)</term><term>Adénovirus humains (immunologie)</term><term>Adénovirus humains (métabolisme)</term><term>Animaux</term><term>Antigène d'histocompatibilité H2-D</term><term>Antigènes H-2 (métabolisme)</term><term>Cartographie épitopique</term><term>Cellules Vero</term><term>Codon</term><term>Données de séquences moléculaires</term><term>Déterminants antigéniques des lymphocytes T (immunologie)</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires (génétique)</term><term>Glycoprotéines membranaires (immunologie)</term><term>Humains</term><term>Immunisation</term><term>Lignée cellulaire</term><term>Lymphocytes T CD8+ (immunologie)</term><term>Peptides ()</term><term>Peptides (immunologie)</term><term>Protéines de l'enveloppe virale (génétique)</term><term>Protéines de l'enveloppe virale (immunologie)</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Souris de lignée C57BL</term><term>Syndrome respiratoire aigu sévère ()</term><term>Séquence d'acides aminés</term><term>Vaccins antiviraux (administration et posologie)</term><term>Vaccins antiviraux (immunologie)</term><term>Vecteurs génétiques (administration et posologie)</term><term>Vecteurs génétiques (immunologie)</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Peptides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Glycoproteins</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Epitopes, T-Lymphocyte</term><term>Membrane Glycoproteins</term><term>Peptides</term><term>Viral Envelope Proteins</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>H-2 Antigens</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Codon</term><term>Histocompatibility Antigen H-2D</term><term>Spike Glycoprotein, Coronavirus</term></keywords><keywords scheme="MESH" qualifier="administration & dosage" xml:lang="en"><term>Genetic Vectors</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antiviraux</term><term>Vecteurs génétiques</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Adenoviruses, Human</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Adénovirus humains</term><term>Glycoprotéines membranaires</term><term>Protéines de l'enveloppe virale</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Adénovirus humains</term><term>Déterminants antigéniques des lymphocytes T</term><term>Glycoprotéines membranaires</term><term>Lymphocytes T CD8+</term><term>Peptides</term><term>Protéines de l'enveloppe virale</term><term>Vaccins antiviraux</term><term>Vecteurs génétiques</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Adenoviruses, Human</term><term>CD8-Positive T-Lymphocytes</term><term>Genetic Vectors</term><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Adenoviruses, Human</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Adénovirus humains</term><term>Antigènes H-2</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Cell Line</term><term>Chlorocebus aethiops</term><term>Epitope Mapping</term><term>Humans</term><term>Immunization</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Mice, Inbred C57BL</term><term>Molecular Sequence Data</term><term>Vero Cells</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Antigène d'histocompatibilité H2-D</term><term>Cartographie épitopique</term><term>Cellules Vero</term><term>Codon</term><term>Données de séquences moléculaires</term><term>Glycoprotéine de spicule des coronavirus</term><term>Humains</term><term>Immunisation</term><term>Lignée cellulaire</term><term>Peptides</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Souris de lignée C57BL</term><term>Syndrome respiratoire aigu sévère</term><term>Séquence d'acides aminés</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding codon-optimized SARS-CoV spike protein. CD8 T-cell responses were mapped to two H-2(b)-restricted epitopes (S436-443 and S525-532) and one H-2(d)-restricted epitope (S366-374). The identification of these epitopes will facilitate the evaluation of vaccine strategies in murine models of SARS-CoV infection. Furthermore, codon and promoter optimizations can greatly enhance the overall immunogenicity of spike protein in the context of replication-defective human and simian adenoviral vaccine carriers. The optimized recombinant adenoviral vaccine vectors encoding spike can generate robust antigen-specific cellular immunity in mice and may potentially be useful for control of SARS-CoV infection.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15823604</PMID><DateCompleted><Year>2005</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0042-6822</ISSN><JournalIssue CitedMedium="Print"><Volume>335</Volume><Issue>1</Issue><PubDate><Year>2005</Year><Month>Apr</Month><Day>25</Day></PubDate></JournalIssue><Title>Virology</Title><ISOAbbreviation>Virology</ISOAbbreviation></Journal><ArticleTitle>Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.</ArticleTitle><Pagination><MedlinePgn>34-45</MedlinePgn></Pagination><Abstract><AbstractText>The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding codon-optimized SARS-CoV spike protein. CD8 T-cell responses were mapped to two H-2(b)-restricted epitopes (S436-443 and S525-532) and one H-2(d)-restricted epitope (S366-374). The identification of these epitopes will facilitate the evaluation of vaccine strategies in murine models of SARS-CoV infection. Furthermore, codon and promoter optimizations can greatly enhance the overall immunogenicity of spike protein in the context of replication-defective human and simian adenoviral vaccine carriers. The optimized recombinant adenoviral vaccine vectors encoding spike can generate robust antigen-specific cellular immunity in mice and may potentially be useful for control of SARS-CoV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhi</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, and The Wistar Institute, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobinger</LastName><ForeName>Gary P</ForeName><Initials>GP</Initials></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Suchma</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Susan R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Hao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Schumer</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Guangping</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Boyer</LastName><ForeName>Julie L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Crystal</LastName><ForeName>Ronald G</ForeName><Initials>RG</Initials></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virology</MedlineTA><NlmUniqueID>0110674</NlmUniqueID><ISSNLinking>0042-6822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003062">Codon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006183">H-2 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064532">Histocompatibility Antigen H-2D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000260" MajorTopicYN="N">Adenoviruses, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003062" MajorTopicYN="N">Codon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="Y">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006183" MajorTopicYN="N">H-2 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064532" MajorTopicYN="N">Histocompatibility Antigen H-2D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>08</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2004</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>4</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>6</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>4</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15823604</ArticleId><ArticleId IdType="pii">S0042-6822(05)00062-0</ArticleId><ArticleId IdType="doi">10.1016/j.virol.2005.01.050</ArticleId><ArticleId IdType="pmc">PMC7111773</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Invest. 2003 Jun;111(11):1605-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12782660</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1989 Jul;63(7):3051-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2542613</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>AIDS Res Hum Retroviruses. 2003 Sep;19(9):817-23</Citation><ArticleIdList><ArticleId IdType="pubmed">14585212</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 1998 Jul;178(1):92-100</Citation><ArticleIdList><ArticleId IdType="pubmed">9652427</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Immunogenetics. 1999 Nov;50(3-4):213-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10602881</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hum Gene Ther. 2004 May;15(5):519-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15144581</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2003 Oct;77(20):10780-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14512528</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1997 Nov 10;238(1):68-78</Citation><ArticleIdList><ArticleId IdType="pubmed">9375010</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2004 Jan 26;22(5-6):697-703</Citation><ArticleIdList><ArticleId IdType="pubmed">14741162</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Gene Ther. 2003 Oct;10(22):1926-30</Citation><ArticleIdList><ArticleId IdType="pubmed">14502222</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Immunol. 2003 Oct 15;171(8):4287-93</Citation><ArticleIdList><ArticleId IdType="pubmed">14530353</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Immunology. 1995 Apr;84(4):521-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7790024</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hum Gene Ther. 2000 Jan 1;11(1):213-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10646652</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2002 Mar;76(6):2667-75</Citation><ArticleIdList><ArticleId IdType="pubmed">11861833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(11):5612-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15140958</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2002 Jan 17;415(6869):331-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11797011</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2000 Nov 30;408(6812):605-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11117750</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 2003 Jan 20;305(2):397-405</Citation><ArticleIdList><ArticleId IdType="pubmed">12573585</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1995 Dec;69(12):8127-31</Citation><ArticleIdList><ArticleId IdType="pubmed">7494335</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation><ArticleIdList><ArticleId IdType="pubmed">12927536</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Gene. 1991 Dec 15;108(2):193-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1660837</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1990 Sep;64(9):4589-92</Citation><ArticleIdList><ArticleId IdType="pubmed">2166833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1996 May 1;219(1):220-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8623532</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Immunol. 1997 Jul 15;159(2):685-93</Citation><ArticleIdList><ArticleId IdType="pubmed">9218583</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hum Mol Genet. 1996 Nov;5(11):1703-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8922997</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Immunol. 2003 Feb 1;170(3):1416-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12538702</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 1996 Feb;77 ( Pt 2 ):315-25</Citation><ArticleIdList><ArticleId IdType="pubmed">8627236</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(12):6134-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15163706</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2001 Nov;75(22):10991-1001</Citation><ArticleIdList><ArticleId IdType="pubmed">11602739</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Immunol. 2003 Dec 15;171(12):6774-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14662882</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2004 Apr;78(7):3572-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15016880</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2003 Oct 1;21(27-30):4095-104</Citation><ArticleIdList><ArticleId IdType="pubmed">14505885</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15010527</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation><ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1989 Dec;173(2):664-73</Citation><ArticleIdList><ArticleId IdType="pubmed">2556846</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 Oct 30;425(6961):915</Citation><ArticleIdList><ArticleId IdType="pubmed">14586458</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2004 Jul;78(14):7392-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15220412</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Immunol. 1998 Mar 15;160(6):2896-904</Citation><ArticleIdList><ArticleId IdType="pubmed">9510193</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2004 May;78(9):4552-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15078936</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2004 Oct;78(20):11416-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15452265</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation><ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10817-22</Citation><ArticleIdList><ArticleId IdType="pubmed">11526203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002797 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002797 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:15823604
|texte= Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:15823604" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |